References
- DeSantisCMaJBryanLJemalABreast cancer statistics, 2013CA Cancer J Clin2014641526224114568
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
- BensonJRJatoiIThe global breast cancer burdenFuture Oncol20128669770222764767
- HustonTLSimmonsRMLocally recurrent breast cancer after conservation therapyAm J Surg2005189222923515720997
- SmithICHeysSDHutcheonAWNeoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxelJ Clin Oncol20022061456146611896092
- BroeckelJAJacobsenPBHortonJBalducciLLymanGHCharacteristics and correlates of fatigue after adjuvant chemotherapy for breast cancerJ Clin Oncol1998165168916969586880
- ChiaSKSpeersCHD’YachkovaYThe impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancerCancer2007110597397917647245
- SpellmanATangSCImmunotherapy for breast cancer: past, present, and futureCancer Metastasis Rev201635452554627913998
- HaddenJWThe immunology and immunotherapy of breast cancer: an updateInt J Immunopharmacol19992127910110230872
- KuboMMorisakiTKurokiHCombination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancerAnticancer Res2003236a4443444914666732
- ZhaoYHuJLiREnhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-beta signaling pathwayOnco Targets Ther201581553155926124672
- ChengMChenYXiaoWSunRTianZNK cell-based immunotherapy for malignant diseasesCell Mol Immunol201310323025223604045
- PapamichailMPerezSAGritzapisADBaxevanisCNNatural killer lymphocytes: biology, development, and functionCancer Immunol Immunother200453317618614685782
- BironCABrossayLNK cells and NKT cells in innate defense against viral infectionsCurr Opin Immunol200113445846411498302
- DewanMZTerunumaHTakadaMRole of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivoBreast Cancer Res Treat2007104326727517066321
- HwangMHLiXJKimJEPotential therapeutic effect of natural killer cells on doxorubicin-resistant breast cancer cells in vitroPLoS One2015108e013620926295571
- RobertiMPMordohJLevyEMBiological role of NK cells and immunotherapeutic approaches in breast cancerFront Immunol2012337523248625
- MikelsaarAVSunterAMikelsaarREpitope of titin A-band-specific monoclonal antibody Tit1 5 H1.1 is highly conserved in several Fn3 domains of the titin molecule. Centriole staining in human, mouse and zebrafish cellsCell Div2012712122985877
- BurnsLJWeisdorfDJDeForTEIL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trialBone Marrow Transplant200332217718612838283
- ReFStaudacherCZamaiLVecchioVBregniMKiller cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumorsCancer2006107364064816804934
- GellerMACooleySJudsonPLA phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancerCytotherapy20111319810720849361
- ZhangMDanielSHuangYAnti-west nile virus activity of in vitro expanded human primary natural killer cellsBMC Immunol201011320089143
- WittCSChristiansenFTThe relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantationVox Sang2006901102016359351
- FortePBaumannBCSchneiderMKSeebachJDHLA-Cw4 expression on porcine endothelial cells reduces cytotoxicity and adhesion mediated by CD158a+ human NK cellsXenotransplantation2009161192619243557
- KunertKSeilerMMashreghiMFKIR/HLA ligand incompatibility in kidney transplantationTransplantation200784111527153318091530
- MorettaLMorettaAKiller immunoglobulin-like receptorsCurr Opin Immunol200416562663315342010
- ImaiCIwamotoSCampanaDGenetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cellsBlood2005106137638315755898
- TsuchidaYTherassePResponse evaluation criteria in solid tumors (RECIST): new guidelinesMed Pediatr Oncol20013711311466715
- GoldbergSNGrassiCJCardellaJFImage-guided tumor ablation: standardization of terminology and reporting criteriaJ Vasc Interv Radiol200516676577815947040
- SaphnerTTormeyDCGrayRAnnual hazard rates of recurrence for breast cancer after primary therapyJ Clin Oncol19961410273827468874335
- FisherBRedmondCPoissonREight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancerN Engl J Med1989320138228282927449
- NagallaSChouJWWillinghamMCInteractions between immunity, proliferation and molecular subtype in breast cancer prognosisGenome Biol2013144R3423618380
- SchmidtMBohmDvon TorneCThe humoral immune system has a key prognostic impact in node-negative breast cancerCancer Res200868135405541318593943
- PageDBNaidooJMcArthurHLEmerging immunotherapy strategies in breast cancerImmunotherapy20146219520924491092
- ErnstBAndersonKSImmunotherapy for the treatment of breast cancerCurr Oncol Rep2015172525677118
- ChoDKimSKCarsonWE3rdNK cell-based immunotherapy for treating cancer: will it be promising?Korean J Hematol20114613521461294
- LanierLLPhillipsJHInhibitory MHC class I receptors on NK cells and T cellsImmunol Today199617286918808056
- MillerJSSoignierYPanoskaltsis-MortariASuccessful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancerBlood200510583051305715632206
- IliopoulouEGKountourakisPKaramouzisMVA phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancerCancer Immunol Immunother201059121781178920703455
- ZhangBSunTXueLFunctional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancerCarcinogenesis20072851067107317183065
- OsengaKLHankJAAlbertiniMRA phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children’s Oncology GroupClin Cancer Res20061261750175916551859
- ShiJLiYLiangSAnalysis of circulating tumor cells in colorectal cancer liver metastasis patients before and after cryosurgeryCancer Biol Ther201617993594227415969
- ShiJLiYLiangSCirculating tumour cells as biomarkers for evaluating cryosurgery on unresectable hepatocellular carcinomaOncol Rep20163641845185127573435